Invention Grant
- Patent Title: Immunomodulators
-
Application No.: US14874886Application Date: 2015-10-05
-
Publication No.: US09732119B2Publication Date: 2017-08-15
- Inventor: Li-Qiang Sun , Qian Zhao , Eric Mull , Eric P. Gillis , Paul Michael Scola
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Pamela A. Mingo
- Main IPC: C07K7/50
- IPC: C07K7/50 ; C07K7/54 ; A61K38/12 ; A01N43/00 ; C07K7/64 ; A61K45/06 ; C07K7/56 ; C07K7/08 ; A61K38/10 ; G01N33/574 ; A61K38/00
Abstract:
The present disclosure provides novel macrocyclic peptides which inhibit the PD-1/PD-L1 and PD-L1/CD80 protein/protein interaction, and thus are useful for the amelioration of various diseases, including cancer and infectious diseases.
Public/Granted literature
- US20160102122A1 Immunomodulators Public/Granted day:2016-04-14
Information query
